Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Acetylcysteine Effervescent Tablets

Approved

化学药品

Acetylcysteine Effervescent Tablets

ZAMBON ITALIA SRL🇨🇳 National Medical Products Administration

Approval Date: Dec 10, 2019
Approval ID: 7LeagV9F7up
Company: ZAMBON ITALIA SRL
Type: 化学药品

Approval Details

Approval Id: 7LeagV9F7up
Approval Number: 国药准字J20150009
Generic Name: 乙酰半胱氨酸泡腾片
Generic Name En: Acetylcysteine Effervescent Tablets
Trade Name: 富露施
Brand Name: 富露施
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.6g
Reg Date: 2019-12-10
Company Name: ZAMBON ITALIA SRL
Company Address: Via Lillo Del Duca 10, 20091-Bresso(MI), Italy
Production Company Name: zambon s.p.a
Production Company Address: Via Della Chimica No.9 36100 Vicenza, Italy
Company Detail Path: /organization/zambon-italia-srl

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 10, 2019

Approval ID

7LeagV9F7up

Type

化学药品

Back to NMPA Approvals

富露施 - NMPA Drug Approval Details